ハイスループットスクリーニング(HTS)のグローバル市場2024-2028:ターゲット同定&バリデーション、一次&二次スクリーニング、毒性評価、幹細胞研究

【英語タイトル】Global High Throughput Screening (HTS) Market 2024-2028

Technavioが出版した調査資料(IRTNTR44564-23)・商品コード:IRTNTR44564-23
・発行会社(調査会社):Technavio
・発行日:2023年10月13日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

ハイスループットスクリーニング(HTS)の世界市場 2024-2028ハイスループットスクリーニング(HTS)市場は、2023年から2028年の間に199億米ドル成長し、予測期間中のCAGRは12.12%で加速すると予測されています。当レポートでは、ハイスループットスクリーニング(HTS)市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、研究開発投資の増加、慢性疾患の有病率の増加、医薬品の特許切れなどが原動力となっています。

Technavio社のハイスループットスクリーニング(HTS)市場は以下のように分類されます:
用途別
- ターゲット同定とバリデーション
- 一次および二次スクリーニング
- 毒性評価
- 幹細胞研究

エンドユーザー別
- 製薬・バイオテクノロジー企業
- 学術・研究機関
- CRO

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間におけるハイスループットスクリーニング(HTS)市場の成長を促進する主な理由の1つとして、プロモーション活動への注目の高まりを挙げています。また、アウトソーシング活動の成長とハイスループットスクリーニングサービスの技術的進歩は、市場の大きな需要につながるでしょう。

この調査レポートは、ハイスループットスクリーニング(HTS)市場を調査・分析した結果をまとめたものです。
- ハイスループットスクリーニング(HTS)市場規模
- ハイスループットスクリーニング(HTS)市場予測
- ハイスループットスクリーニング(HTS)市場の産業分析

本レポートでは、ハイスループット・スクリーニング(HTS)市場の主要ベンダーであるAgilent Technologies Inc.、Aurora Biomed Inc.、Axxam Spa、Beckman Coulter Inc.、Bio Rad Laboratories Inc、 Biomat Srl、BMG LABTECH GmbH、Charles River Laboratories International Inc.、Corning Inc.、Danaher Corp.、DIANA Biotechnologies s.r.o.、HighRes Biosolutions、JSR Life Sciences LLC、Lonza Group Ltd.、Merck KGaA、NanoTemper Technologies GmbH、PerkinElmer Inc.、Sygnature Discovery Ltd.、Tecan Trading AG、Thermo Fisher Scientific Inc.などを分析しています。また、ハイスループットスクリーニング(HTS)市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 ハイスループットスクリーニング(HTS)の世界市場:用途別市場分析
7 ハイスループットスクリーニング(HTS)の世界市場:エンドユーザー別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global high throughput screening (HTS) market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global high throughput screening (hts) market 2018 – 2022 ($ billion)
o 4.2 Application Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Application Segment 2018 – 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – End-user Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application – Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Target identification and validation – Market size and forecast 2023-2028
o Exhibit 34: Chart on Target identification and validation – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Target identification and validation – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Target identification and validation – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Target identification and validation – Year-over-year growth 2023-2028 (%)
o 6.4 Primary and secondary screening – Market size and forecast 2023-2028
o Exhibit 38: Chart on Primary and secondary screening – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Primary and secondary screening – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Primary and secondary screening – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Primary and secondary screening – Year-over-year growth 2023-2028 (%)
o 6.5 Toxicology assessment – Market size and forecast 2023-2028
o Exhibit 42: Chart on Toxicology assessment – Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Toxicology assessment – Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Toxicology assessment – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Toxicology assessment – Year-over-year growth 2023-2028 (%)
o 6.6 Stem cell research – Market size and forecast 2023-2028
o Exhibit 46: Chart on Stem cell research – Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Stem cell research – Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Stem cell research – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Stem cell research – Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ billion)
o Exhibit 51: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 53: Data Table on End-user – Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2023-2028 (%)
o 7.4 Academic and research institutes – Market size and forecast 2023-2028
o Exhibit 60: Chart on Academic and research institutes – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Academic and research institutes – Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Academic and research institutes – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Academic and research institutes – Year-over-year growth 2023-2028 (%)
o 7.5 CROs – Market size and forecast 2023-2028
o Exhibit 64: Chart on CROs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on CROs – Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on CROs – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on CROs – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 68: Market opportunity by End-user ($ billion)
o Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 Japan – Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.10 France – Market size and forecast 2023-2028
o Exhibit 103: Chart on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.11 China – Market size and forecast 2023-2028
o Exhibit 107: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 119: Agilent Technologies Inc. – Overview
o Exhibit 120: Agilent Technologies Inc. – Business segments
o Exhibit 121: Agilent Technologies Inc. – Key offerings
o Exhibit 122: Agilent Technologies Inc. – Segment focus
o 12.4 Aurora Biomed Inc.
o Exhibit 123: Aurora Biomed Inc. – Overview
o Exhibit 124: Aurora Biomed Inc. – Product / Service
o Exhibit 125: Aurora Biomed Inc. – Key offerings
o 12.5 Axxam Spa
o Exhibit 126: Axxam Spa – Overview
o Exhibit 127: Axxam Spa – Product / Service
o Exhibit 128: Axxam Spa – Key offerings
o 12.6 Beckman Coulter Inc.
o Exhibit 129: Beckman Coulter Inc. – Overview
o Exhibit 130: Beckman Coulter Inc. – Product / Service
o Exhibit 131: Beckman Coulter Inc. – Key offerings
o 12.7 Bio Rad Laboratories Inc.
o Exhibit 132: Bio Rad Laboratories Inc. – Overview
o Exhibit 133: Bio Rad Laboratories Inc. – Business segments
o Exhibit 134: Bio Rad Laboratories Inc. – Key news
o Exhibit 135: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 136: Bio Rad Laboratories Inc. – Segment focus
o 12.8 Charles River Laboratories International Inc.
o Exhibit 137: Charles River Laboratories International Inc. – Overview
o Exhibit 138: Charles River Laboratories International Inc. – Business segments
o Exhibit 139: Charles River Laboratories International Inc. – Key news
o Exhibit 140: Charles River Laboratories International Inc. – Key offerings
o Exhibit 141: Charles River Laboratories International Inc. – Segment focus
o 12.9 Corning Inc.
o Exhibit 142: Corning Inc. – Overview
o Exhibit 143: Corning Inc. – Business segments
o Exhibit 144: Corning Inc. – Key news
o Exhibit 145: Corning Inc. – Key offerings
o Exhibit 146: Corning Inc. – Segment focus
o 12.10 Danaher Corp.
o Exhibit 147: Danaher Corp. – Overview
o Exhibit 148: Danaher Corp. – Business segments
o Exhibit 149: Danaher Corp. – Key news
o Exhibit 150: Danaher Corp. – Key offerings
o Exhibit 151: Danaher Corp. – Segment focus
o 12.11 Lonza Group Ltd.
o Exhibit 152: Lonza Group Ltd. – Overview
o Exhibit 153: Lonza Group Ltd. – Business segments
o Exhibit 154: Lonza Group Ltd. – Key news
o Exhibit 155: Lonza Group Ltd. – Key offerings
o Exhibit 156: Lonza Group Ltd. – Segment focus
o 12.12 Merck KGaA
o Exhibit 157: Merck KGaA – Overview
o Exhibit 158: Merck KGaA – Business segments
o Exhibit 159: Merck KGaA – Key news
o Exhibit 160: Merck KGaA – Key offerings
o Exhibit 161: Merck KGaA – Segment focus
o 12.13 NanoTemper Technologies GmbH
o Exhibit 162: NanoTemper Technologies GmbH – Overview
o Exhibit 163: NanoTemper Technologies GmbH – Product / Service
o Exhibit 164: NanoTemper Technologies GmbH – Key offerings
o 12.14 PerkinElmer Inc.
o Exhibit 165: PerkinElmer Inc. – Overview
o Exhibit 166: PerkinElmer Inc. – Business segments
o Exhibit 167: PerkinElmer Inc. – Key news
o Exhibit 168: PerkinElmer Inc. – Key offerings
o Exhibit 169: PerkinElmer Inc. – Segment focus
o 12.15 Sygnature Discovery Ltd.
o Exhibit 170: Sygnature Discovery Ltd. – Overview
o Exhibit 171: Sygnature Discovery Ltd. – Product / Service
o Exhibit 172: Sygnature Discovery Ltd. – Key offerings
o 12.16 Tecan Trading AG
o Exhibit 173: Tecan Trading AG – Overview
o Exhibit 174: Tecan Trading AG – Business segments
o Exhibit 175: Tecan Trading AG – Key offerings
o Exhibit 176: Tecan Trading AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 177: Thermo Fisher Scientific Inc. – Overview
o Exhibit 178: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 179: Thermo Fisher Scientific Inc. – Key news
o Exhibit 180: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 181: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global high throughput screening (hts) market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Application Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – End-user Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Application – Market share 2023-2028 (%)
Exhibits31: Data Table on Application – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Target identification and validation – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Target identification and validation – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Target identification and validation – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Target identification and validation – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Primary and secondary screening – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Primary and secondary screening – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Primary and secondary screening – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Primary and secondary screening – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Toxicology assessment – Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Toxicology assessment – Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Toxicology assessment – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Toxicology assessment – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Stem cell research – Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Stem cell research – Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Stem cell research – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Stem cell research – Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Application ($ billion)
Exhibits51: Data Table on Market opportunity by Application ($ billion)
Exhibits52: Chart on End-user – Market share 2023-2028 (%)
Exhibits53: Data Table on End-user – Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Academic and research institutes – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Academic and research institutes – Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Academic and research institutes – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Academic and research institutes – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on CROs – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on CROs – Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on CROs – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on CROs – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by End-user ($ billion)
Exhibits69: Data Table on Market opportunity by End-user ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Agilent Technologies Inc. – Overview
Exhibits120: Agilent Technologies Inc. – Business segments
Exhibits121: Agilent Technologies Inc. – Key offerings
Exhibits122: Agilent Technologies Inc. – Segment focus
Exhibits123: Aurora Biomed Inc. – Overview
Exhibits124: Aurora Biomed Inc. – Product / Service
Exhibits125: Aurora Biomed Inc. – Key offerings
Exhibits126: Axxam Spa – Overview
Exhibits127: Axxam Spa – Product / Service
Exhibits128: Axxam Spa – Key offerings
Exhibits129: Beckman Coulter Inc. – Overview
Exhibits130: Beckman Coulter Inc. – Product / Service
Exhibits131: Beckman Coulter Inc. – Key offerings
Exhibits132: Bio Rad Laboratories Inc. – Overview
Exhibits133: Bio Rad Laboratories Inc. – Business segments
Exhibits134: Bio Rad Laboratories Inc. – Key news
Exhibits135: Bio Rad Laboratories Inc. – Key offerings
Exhibits136: Bio Rad Laboratories Inc. – Segment focus
Exhibits137: Charles River Laboratories International Inc. – Overview
Exhibits138: Charles River Laboratories International Inc. – Business segments
Exhibits139: Charles River Laboratories International Inc. – Key news
Exhibits140: Charles River Laboratories International Inc. – Key offerings
Exhibits141: Charles River Laboratories International Inc. – Segment focus
Exhibits142: Corning Inc. – Overview
Exhibits143: Corning Inc. – Business segments
Exhibits144: Corning Inc. – Key news
Exhibits145: Corning Inc. – Key offerings
Exhibits146: Corning Inc. – Segment focus
Exhibits147: Danaher Corp. – Overview
Exhibits148: Danaher Corp. – Business segments
Exhibits149: Danaher Corp. – Key news
Exhibits150: Danaher Corp. – Key offerings
Exhibits151: Danaher Corp. – Segment focus
Exhibits152: Lonza Group Ltd. – Overview
Exhibits153: Lonza Group Ltd. – Business segments
Exhibits154: Lonza Group Ltd. – Key news
Exhibits155: Lonza Group Ltd. – Key offerings
Exhibits156: Lonza Group Ltd. – Segment focus
Exhibits157: Merck KGaA – Overview
Exhibits158: Merck KGaA – Business segments
Exhibits159: Merck KGaA – Key news
Exhibits160: Merck KGaA – Key offerings
Exhibits161: Merck KGaA – Segment focus
Exhibits162: NanoTemper Technologies GmbH – Overview
Exhibits163: NanoTemper Technologies GmbH – Product / Service
Exhibits164: NanoTemper Technologies GmbH – Key offerings
Exhibits165: PerkinElmer Inc. – Overview
Exhibits166: PerkinElmer Inc. – Business segments
Exhibits167: PerkinElmer Inc. – Key news
Exhibits168: PerkinElmer Inc. – Key offerings
Exhibits169: PerkinElmer Inc. – Segment focus
Exhibits170: Sygnature Discovery Ltd. – Overview
Exhibits171: Sygnature Discovery Ltd. – Product / Service
Exhibits172: Sygnature Discovery Ltd. – Key offerings
Exhibits173: Tecan Trading AG – Overview
Exhibits174: Tecan Trading AG – Business segments
Exhibits175: Tecan Trading AG – Key offerings
Exhibits176: Tecan Trading AG – Segment focus
Exhibits177: Thermo Fisher Scientific Inc. – Overview
Exhibits178: Thermo Fisher Scientific Inc. – Business segments
Exhibits179: Thermo Fisher Scientific Inc. – Key news
Exhibits180: Thermo Fisher Scientific Inc. – Key offerings
Exhibits181: Thermo Fisher Scientific Inc. – Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations



★調査レポート[ハイスループットスクリーニング(HTS)のグローバル市場2024-2028:ターゲット同定&バリデーション、一次&二次スクリーニング、毒性評価、幹細胞研究] (コード:IRTNTR44564-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[ハイスループットスクリーニング(HTS)のグローバル市場2024-2028:ターゲット同定&バリデーション、一次&二次スクリーニング、毒性評価、幹細胞研究]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆